Fenwick Represents Woebot Health in its $90 Million Series B Financing

Fenwick represented Woebot Health, a pioneer in the development of relational tools and technologies for mental health, in its $90 million Series B financing. The round was co-led by existing investor JAZZ Venture Partners and Temasek with participation from funds and accounts managed by BlackRock Private Equity Partners and Owl Ventures. Additional participants include Mirae Asset Capital, Kicker Ventures, Alumni Ventures and Gaingels as well as existing investors NEA and AI Fund.

Woebot Health will use the proceeds to accelerate further development of its relational platform and technologies, advance its lead digital therapeutic candidates and expand its team and go-to-market activities to meet surging global demand for mental health care. More information can be obtained from Woebot Health's announcement.

The Fenwick transaction team was led by corporate partner Steven Levine as well as corporate associates James Li and Summer Yin.